🇺🇸 FDA
Pipeline program

Para-Tabs 500 mg tabletti, ODM-111 Placebo, ODM-111, ODM-111

3133004

Phase 2 small_molecule active

Quick answer

Para-Tabs 500 mg tabletti, ODM-111 Placebo, ODM-111, ODM-111 for CHRONIC PAIN DUE TO DIABETIC PERIPHERAL NEUROPATHY is a Phase 2 program (small_molecule) at Orion with 1 ClinicalTrials.gov record(s).

Program details

Company
Orion
Indication
CHRONIC PAIN DUE TO DIABETIC PERIPHERAL NEUROPATHY
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials